UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM
8-K/A
(Amendment
No.1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): August 11, 2009
Cornerstone Therapeutics Inc.
(Exact Name of Registrant as Specified in Its Charter)
| |
|
|
|
|
| Delaware
|
|
000-50767
|
|
04-3523569 |
| (State or Other Jurisdiction
|
|
(Commission
|
|
(IRS Employer |
| of Incorporation)
|
|
File Number)
|
|
Identification No.) |
| |
|
|
| |
|
|
| 1255 Crescent Green Drive, Suite 250, Cary, NC
|
|
27518 |
| (Address of Principal Executive Offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code: (919) 678-6611
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
TABLE OF CONTENTS
EXPLANATORY
NOTE
This
amendment to the Current Report on Form 8-K filed by Cornerstone
Therapeutics Inc. (the “Company”) with the Securities and
Exchange Commission on August 11, 2009 is filed solely to correct a
clerical error whereby the wrong version of the Company's press
release dated August 11, 2009 was filed as Exhibit 99.1 to the
original Form 8-K. The correct version of the Company's press release
is filed as Exhibit 99.1 to this amendment.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
See the Exhibit Index attached hereto.